Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia
in non-human immunodeficiency virusinfected patients: retrospective study of 31 patients.
Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia
treated with corticosteroids?
40 for the variable Pneumocystis carinii pneumonia
in Table 3 implies that patient who have Pneumocystis carinii pneumonia
are more than twice as likely to receive antiretroviral medications as patients with HIV disease who have not had Pneurnocystis carinii pneumonia.
Approved June 23, 1981 for the treatment of Pneumocystis carinii pneumonia
These infections, which include Pneumocystis carinii pneumonia
, are a major danger to persons with AIDS but generally would not occur or would not be serious in someone with a normally functioning immune system.
Risk factors for Pneumocystis carinii pneumonia
in kidney transplant recipients: a case-control study.
Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report described cases of Kaposi's sarcoma (KS) and pneumocystis carinii pneumonia
(PCP) in young, previously healthy gay men.
Atovaquone is marketed in the United States under the trade name Mepron for Pneumocystis carinii pneumonia
In addition to conditions such as Pneumocystis carinii pneumonia
that afflict HIV-infected people of both genders, women suffer gender-specific manifestations of HIV disease, such as recurrent vaginal yeast infections and pelvic inflammatory disease.
Disease progression was defined as the onset of a new AIDS-related illness like thrush in the gullet, a cancer known as Kaposi's sarcoma, infection of the retina with cytomegalovirus or pneumocystis carinii pneumonia
However, the authors of the studies conclude that because it produces fewer side effects than TMP/SMX, aerosolized pentamidine may still prove preferable for protecting some AIDS patients from Pneumocystis carinii pneumonia
Sulfamethoxazole with Trimethoprim is used to treat infections such as urinary tract infections, bronchitis, ear infections (otitis), traveler's diarrhea, and Pneumocystis carinii pneumonia
and is the generic equivalent of Bactrim(R) and Bactrim DS(R), marketed by United Research Laboratories, Inc.